👀 Copy Legendary Investors' Portfolios in One ClickCopy For Free

Europe stocks dip as Italian banks hit by windfall tax; Novo Nordisk jumps

Published 08/08/2023, 03:23 AM
Updated 08/08/2023, 12:16 PM
© Reuters. FILE PHOTO: The German share price index DAX graph is pictured at the stock exchange in Frankfurt, Germany, August 7, 2023. REUTERS/Staff/File Photo
DE40
-
IT40
-
MCO
-
STOXX
-
ISNPY
-

By Shashwat Chauhan, Amruta Khandekar and Shristi Achar A

(Reuters) -European shares fell on Tuesday as Italian banks were hit after the cabinet approved a 40% windfall tax on lenders, though a jump in shares of drugmaker Novo Nordisk (NYSE:NVO) after positive data on its obesity drug helped limit losses.

Italian banks such as Intesa Sanpaolo (OTC:ISNPY), Banco BPM and UniCredit fell between 5% and 9.1% after Deputy Prime Minister Matteo Salvini said a 40% levy on banks' extra profits will fund items such as a reduction of the tax wedge, tax cuts and financial support to holders of mortgages on first homes.

The pan-European STOXX 600 index fell 0.2%, while Italy's banking-heavy FTSE MIB, which had rallied to multi-year highs recently, dropped 2.1% to hit its lowest level in four weeks.

Broader euro zone banks tumbled 3.5% in their worst day since March, also hurt by news that ratings agency Moody's (NYSE:MCO) cut credit ratings of several small- to mid-sized U.S. banks and said it may downgrade some of the biggest lenders in the United States.

China-exposed miners shed 1.8% after data revealed imports and exports in the world's second-largest economy fell much faster than expected in July, threatening growth prospects and heightening pressure on Beijing to provide fresh stimulus.

"Both of those factors (Italian windfall taxes and weak China trade data) are contributing to this risk aversion that's sweeping across markets," said Laura Cooper, senior macro strategist for iShares EMEA at BlackRock (NYSE:BLK).

"When we look at Italian banks, we are seeing signs of pressure but this is coming after quite exceptional performance where the FTSE MIB has been the outlier across the continent."

Novo Nordisk soared 17.3% to a record high, causing its market value to top $300 billion, after the Danish drugmaker said a large study had shown its obesity treatment Wegovy also had a clear cardiovascular benefit.

Hopes that the Federal Reserve and the European Central Bank (ECB) are near the end of their tightening cycle had pushed the STOXX 600 to over one-year highs last month. But markets have hit a rough patch recently on reports showing slowing economic growth in Europe and China.

© Reuters. FILE PHOTO: The German share price index DAX graph is pictured at the stock exchange in Frankfurt, Germany, August 7, 2023. REUTERS/Staff/File Photo

"It is just underpinning this challenging macro backdrop that markets have ignored more recently, focusing more on the soft landing narrative that they're seeing play out in the U.S.," Cooper added.

Germany's DAX index fell 1.1% after data showed inflation eased to 6.5% in July, in line with economists' expectations.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.